OKYO Pharma Limited Operating Expense Excluding Cost Of Sales
OKYO Pharma Limited (OKYO) reported Operating Expense Excluding Cost Of Sales of $7.09 million for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-18.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OperatingExpenseExcludingCostOfSales · last filed 2025-07-18
| Period end | Operating Expense Excluding Cost Of Sales 12 month |
|---|---|
| 2025-03-31 | $7.09M 20-F · filed 2025-07-18 |
| 2024-03-31 | $15.75M 20-F · filed 2025-07-18 |
| 2023-03-31 | $13.19M 20-F · filed 2025-07-18 |
| 2022-03-31 | $6.22M 20-F · filed 2024-08-13 |
| 2021-03-31 | $3.37M 20-F · filed 2023-08-15 |
| 2020-03-31 | $1.53M 20-F · filed 2022-08-15 |